MiMedx Group Inc (MDXG) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.94
• Market Cap: $781.98M
• P/E Ratio: 19.56
• EPS: $0.27
• 52-Week High: $8.46
• 52-Week Low: $4.89

Market Sentiment

MiMedx Group Inc currently has a Bullish sentiment score of 0.26.

About MiMedx Group Inc

MiMedx Group, Inc. (MDXG) is a leading regenerative medicine company headquartered in Marietta, Georgia, specializing in the development and distribution of cutting-edge placental tissue allografts. These innovative products play a vital role in both wound care and surgical applications, significantly enhancing healing processes and improving patient outcomes. Leveraging proprietary technologies and a strong research foundation, MiMedx is strategically positioned to meet the dynamic needs of ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for MiMedx Group Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MDXG pay dividends?

MiMedx Group Inc (MDXG) does not currently pay a regular dividend.

What is MDXG's P/E ratio?

MiMedx Group Inc has a price-to-earnings (P/E) ratio of 19.56.

What is MDXG's market cap?

MiMedx Group Inc (MDXG) has a market capitalization of $781.98M with a current stock price of $4.94.